title: [Miliary tuberculosis in a patient with Crohn's disease].
authors: Isabel
authors: I
authors: Ferrer
authors: Nuria
authors: N
authors: Maroto
authors: Cristina
authors: C
authors: Montón
authors: Rosana
authors: R
authors: Villagrasa
authors: Antonio
authors: A
authors: López
authors: Joan
authors: J
authors: Clofent
authors: Joaquín
authors: J
authors: Hinojosa
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001999:Bronchoscopy; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D004198:Disease Susceptibility; D004359:Drug Therapy, Combination; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013166:Spondylitis / Q000209:etiology; D014374:Tuberculin Test; D014391:Tuberculosis, Miliary / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D000995:Antitubercular Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D011718:Pyrazinamide; D000069285:Infliximab; D001379:Azathioprine; D007538:Isoniazid; D012293:Rifampin